Fundraising FoxPainqx
Kennett Square, US · Delaware corporation · 3 known investors
Find your way into Painqx
Sign up to see every warm intro you have to Painqx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Painqx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
FM
Frank MinellaExecutiveFrank Minella is founder and CEO of PainQx, a medical technology company developing biomarkers to objectively measure pain for clinical research and drug development. He has experience as a pilot and has founded multiple companies in the life sciences sector.
AR
Alexander RuckdaeschelExecutive
Board
JH
John H. StewartBoard director
AK
Andrew KoopmanBoard director
Investors · 3
Reported raises · per SEC filings
Form D private placements$2.3M disclosed across 2 rounds · 2017–2021
▶$736.4KraisedMay 2021 · 6 investors · BiotechnologyRule 506(b)
▶$736.4KraisedMay 2021 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Frank MinellaExecutive Officer, Director
- Alexander RuckdaeschelExecutive Officer, Director
- John H. StewartDirector
- Andrew KoopmanDirector
- Offering amount
- $2.5M
- Amount sold
- $736.4K
- First sale
- Apr 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.6MraisedMay 2018 · 41 investors · BiotechnologyRule 506(b)
▶$1.6MraisedMay 2018 · 41 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Alex RuckdaeschelDirector
- Frank MinellaExecutive Officer, Director
- Offering amount
- $1.8M
- Amount sold
- $1.6M
- First sale
- Aug 2017
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 3 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| Department of DefenseDefense Health Program | Phase II | 2021 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2019 | $1.4M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $219.4K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- Who are Painqx's investors?
- Painqx's investors include Delaware Crossing Investor Group, Italian Angels for Growth, NYU Innovation Venture Fund.
- How much funding has Painqx raised?
- Painqx has disclosed $2.3M raised across 2 rounds.
- Where is Painqx headquartered?
- Painqx is headquartered in Kennett Square, US.